AKT1 and ovarian cancer: Cisplatin induced an increase in the level of p-AXL and p-Akt, confirming their roles in cisplatin resistance of ovarian cancer cells; the inductive effect was amplified in SKOV3 cells following overexpression of NTNG1, and an opposite result was observed in SKOV3/DDP cells when silencing NTNG1.